Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs (Q38720238)
Jump to navigation
Jump to search
scientific article published on 20 January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs |
scientific article published on 20 January 2017 |
Statements
1 reference
Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs (English)
1 reference
Julian Andreev
1 reference
Nithya Thambi
1 reference
Andres E Perez Bay
1 reference
Frank Delfino
1 reference
Joel Martin
1 reference
Marcus P Kelly
1 reference
Jessica R Kirshner
1 reference
Ashique Rafique
1 reference
Arthur Kunz
1 reference
Thomas Nittoli
1 reference
Douglas MacDonald
1 reference
Christopher Daly
1 reference
William Olson
1 reference
Gavin Thurston
1 reference
20 January 2017
1 reference
1 reference
16
1 reference
4
1 reference
681-693
1 reference
Identifiers
1 reference
1 reference